About Saluda Medical
Saluda Medical is a company based in Bloomington (United States) founded in 2010. Saluda Medical has raised $530 million across 9 funding rounds from investors including Fidelity Investments, Medtronic and Boston Scientific. Saluda Medical offers products and services including Evoke System and SmartLoop Technology. Saluda Medical operates in a competitive market with competitors including Myoscience, Nalu Medical, Neuros Medical, Biowave and Alpha-Stim, among others.
- Headquarter Bloomington, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Saluda Medical Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$530 M (USD)
in 9 rounds
-
Latest Funding Round
$30 M (USD), Series B
Oct 30, 2025
-
Investors
Fidelity Investments
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Saluda Medical
Saluda Medical is a publicly listed company on the ASX with ticker symbol SLD in Australia. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Saluda Medical
Saluda Medical offers a comprehensive portfolio of products and services, including Evoke System and SmartLoop Technology.
Device for closed-loop spinal cord stimulation to treat chronic pain.
Technology that adjusts neural stimulation based on patient responses.
People of Saluda Medical
Unlock access to complete
Software Development Team
54 people
Senior Team
20 people
Sales and Marketing
11 people
Leadership Team
9 people
Operations Team
8 people
Clinical Team
5 people
Human Resources and Administration
5 people
Product Management Team
4 people
Unlock access to complete
Funding Insights of Saluda Medical
Saluda Medical has successfully raised a total of $530M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Saluda Medical
Saluda Medical has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Medtronic and Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fund of funds focused on pre-seed and seed-stage companies
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US life sciences are pursued.
|
Locked | Locked | Locked | |
|
BioScience Managers is engaged in healthcare investment and innovation.
|
Locked | Locked | Locked |
Investor details for Saluda Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Saluda Medical
Investment portfolio details for Saluda Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Saluda Medical
Detailed financials for Saluda Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Saluda Medical Comparisons
Peer comparison for Saluda Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Saluda Medical
Saluda Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Myoscience, Nalu Medical, Neuros Medical, Biowave and Alpha-Stim, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology-driven dermatological products are developed and commercialized.
|
|
| Locked | Locked | Locked |
Developer of a neurostimulation system for managing intractable chronic pain
|
|
| Locked | Locked | Locked |
High-frequency neurostimulation therapies for chronic neuropathic pain are developed.
|
|
| Locked | Locked | Locked |
Neuromodulation devices are developed for pain therapy management.
|
|
| Locked | Locked | Locked |
Non-drug electrotherapy devices for pain and anxiety are developed.
|
Detailed competitors of Saluda Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Saluda Medical
Complete news archive for Saluda Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saluda Medical
Saluda Medical was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Saluda Medical is headquartered in Bloomington, United States. It is registered at Bloomington, Indiana, United States.
Jim Schuermann is the current CEO of Saluda Medical.
Saluda Medical is a funded company, having raised a total of $530M across 9 funding rounds to date.
Founded in 2010 and headquartered in Bloomington, United States, Saluda Medical operates in the neuromodulation sector. A system is provided that measures and records neural activation characteristics for treating chronic neurological conditions, particularly pain. Stimulation levels are quantified against clinician-defined targets, with continuous comparisons and automatic adjustments to maintain consistent activation. Evoked Compound Action Potentials are utilized to enhance therapy precision.
Saluda Medical's top competitors include Nalu Medical, Myoscience and Neuros Medical.
Saluda Medical offers Evoke System and SmartLoop Technology.
Yes, Saluda Medical is publicly traded on ASX under the ticker symbol SLD.
Saluda Medical has 11 investors. Key investors include Fidelity Investments, Medtronic, Boston Scientific, TPG, and T. Rowe Price.
The ticker symbol of Saluda Medical is SLD on ASX.